BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kholia S, Herrera Sanchez MB, Cedrino M, Papadimitriou E, Tapparo M, Deregibus MC, Bruno S, Antico F, Brizzi MF, Quesenberry PJ, Camussi G. Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy. Front Cell Dev Biol. 2020;8:188. [PMID: 32266268 DOI: 10.3389/fcell.2020.00188] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Mazzariol M, Camussi G, Brizzi MF. Extracellular Vesicles Tune the Immune System in Renal Disease: A Focus on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Thrombotic Microangiopathy and ANCA-Vasculitis. Int J Mol Sci 2021;22:4194. [PMID: 33919576 DOI: 10.3390/ijms22084194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kosanović M, Llorente A, Glamočlija S, Valdivielso JM, Bozic M. Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach. Int J Mol Sci 2021;22:3887. [PMID: 33918699 DOI: 10.3390/ijms22083887] [Reference Citation Analysis]
3 Rampino T, Gregorini M, Germinario G, Pattonieri EF, Erasmi F, Grignano MA, Bruno S, Alomari E, Bettati S, Asti A, Ramus M, De Amici M, Testa G, Bruno S, Ceccarelli G, Serpieri N, Libetta C, Sepe V, Blasevich F, Odaldi F, Maroni L, Vasuri F, La Manna G, Ravaioli M. Extracellular Vesicles Derived from Mesenchymal Stromal Cells Delivered during Hypothermic Oxygenated Machine Perfusion Repair Ischemic/Reperfusion Damage of Kidneys from Extended Criteria Donors. Biology (Basel) 2022;11:350. [PMID: 35336724 DOI: 10.3390/biology11030350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Nowak N, Yamanouchi M, Satake E. The Nephroprotective Properties of Extracellular Vesicles in Experimental Models of Chronic Kidney Disease: a Systematic Review. Stem Cell Rev Rep 2021. [PMID: 34110587 DOI: 10.1007/s12015-021-10189-9] [Reference Citation Analysis]
5 Wiśniewska J, Sadowska A, Wójtowicz A, Słyszewska M, Szóstek-Mioduchowska A. Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies. Life (Basel) 2021;11:1068. [PMID: 34685439 DOI: 10.3390/life11101068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang J, Kong Y, Xie C, Zhou L. Stem/progenitor cell in kidney: characteristics, homing, coordination, and maintenance. Stem Cell Res Ther 2021;12:197. [PMID: 33743826 DOI: 10.1186/s13287-021-02266-0] [Reference Citation Analysis]
7 Ma M, Luo Q, Fan L, Li W, Li Q, Meng Y, Yun C, Wu H, Lu Y, Cui S, Liu F, Hu B, Guan B, Liu H, Huang S, Liang W, Morgera S, Krämer B, Luan S, Yin L, Hocher B. The urinary exosomes derived from premature infants attenuate cisplatin-induced acute kidney injury in mice via microRNA-30a-5p/ mitogen-activated protein kinase 8 (MAPK8). Bioengineered 2022;13:1650-65. [PMID: 35001794 DOI: 10.1080/21655979.2021.2021686] [Reference Citation Analysis]
8 Hajinejad M, Sahab-Negah S. Neuroinflammation: The next target of exosomal microRNAs derived from mesenchymal stem cells in the context of neurological disorders. J Cell Physiol 2021. [PMID: 34189724 DOI: 10.1002/jcp.30495] [Reference Citation Analysis]
9 Grange C, Bussolati B. Extracellular vesicles in kidney disease. Nat Rev Nephrol 2022. [PMID: 35641620 DOI: 10.1038/s41581-022-00586-9] [Reference Citation Analysis]
10 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol 2021;101:108217. [PMID: 34627083 DOI: 10.1016/j.intimp.2021.108217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
11 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. International Immunopharmacology 2021;101:108217. [DOI: 10.1016/j.intimp.2021.108217] [Reference Citation Analysis]
12 Liu Y, Holmes C. Tissue Regeneration Capacity of Extracellular Vesicles Isolated From Bone Marrow-Derived and Adipose-Derived Mesenchymal Stromal/Stem Cells. Front Cell Dev Biol 2021;9:648098. [PMID: 33718390 DOI: 10.3389/fcell.2021.648098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Huang Y, Yang L. Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases. Stem Cell Res Ther 2021;12:435. [PMID: 34348793 DOI: 10.1186/s13287-021-02524-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wong CY. Current advances of stem cell-based therapy for kidney diseases. World J Stem Cells 2021; 13(7): 914-933 [PMID: 34367484 DOI: 10.4252/wjsc.v13.i7.914] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Liao C, Chen G, Yang Q, Liu Y, Zhou T. Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis. Front Cell Dev Biol 2022;10:824752. [DOI: 10.3389/fcell.2022.824752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Goenka V, Borkar T, Desai A, Das RK. Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases. J Diabetes Metab Disord 2020;19:1979-93. [PMID: 33520872 DOI: 10.1007/s40200-020-00647-5] [Reference Citation Analysis]
17 Paris GC, Azevedo AA, Ferreira AL, Azevedo YMA, Rainho MA, Oliveira GP, Silva KR, Cortez EAC, Stumbo AC, Carvalho SN, de Carvalho L, Thole AA. Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19. Life Sci 2021;278:119510. [PMID: 33865879 DOI: 10.1016/j.lfs.2021.119510] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Birtwistle L, Chen XM, Pollock C. Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury. Int J Mol Sci 2021;22:6596. [PMID: 34202940 DOI: 10.3390/ijms22126596] [Reference Citation Analysis]
19 Pomatto M, Gai C, Negro F, Cedrino M, Grange C, Ceccotti E, Togliatto G, Collino F, Tapparo M, Figliolini F, Lopatina T, Brizzi MF, Camussi G. Differential Therapeutic Effect of Extracellular Vesicles Derived by Bone Marrow and Adipose Mesenchymal Stem Cells on Wound Healing of Diabetic Ulcers and Correlation to Their Cargoes. Int J Mol Sci 2021;22:3851. [PMID: 33917759 DOI: 10.3390/ijms22083851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Bruno S, Chiabotto G, Camussi G. Extracellular Vesicles: A Therapeutic Option for Liver Fibrosis. Int J Mol Sci 2020;21:E4255. [PMID: 32549355 DOI: 10.3390/ijms21124255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
21 Gao Z, Zhang C, Peng F, Chen Q, Zhao Y, Chen L, Wang X, Chen X. Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation. Stem Cell Res Ther 2022;13:191. [PMID: 35526054 DOI: 10.1186/s13287-022-02861-9] [Reference Citation Analysis]
22 Huang Y, Yang L. Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases. Stem Cell Res Ther 2021;12:219. [PMID: 33789750 DOI: 10.1186/s13287-021-02289-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Gupta A, Kashte S, Gupta M, Rodriguez HC, Gautam SS, Kadam S. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective. Hum Cell. 2020;33:907-918. [PMID: 32780299 DOI: 10.1007/s13577-020-00407-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
24 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Kholia S, Herrera Sanchez MB, Deregibus MC, Sassoè-Pognetto M, Camussi G, Brizzi MF. Human Liver Stem Cell Derived Extracellular Vesicles Alleviate Kidney Fibrosis by Interfering with the β-Catenin Pathway through miR29b. Int J Mol Sci 2021;22:10780. [PMID: 34639119 DOI: 10.3390/ijms221910780] [Reference Citation Analysis]